Chondroitin sulphate and mast cell alterations in benign prostatic hyperplasia (BPH) and prostatic adenocarcinoma (PCA)

被引:0
|
作者
Magkou, C [1 ]
Koukoumides, C [1 ]
Sitaras, NM [1 ]
机构
[1] Univ Athens, Sch Med, Dept Expt Pharmacol, GR-10679 Athens, Greece
来源
TISSUE ANTIGENS | 2004年 / 64卷 / 04期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:385 / 385
页数:1
相关论文
共 50 条
  • [21] DECISIONAL QUALITY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH)
    Shirk, Joseph
    Lambrechts, Sylvia
    Kwan, Lorna
    Munnangi, Meghana
    Sumal, Amit
    Saigal, Christopher
    JOURNAL OF UROLOGY, 2016, 195 (04): : E278 - E278
  • [22] URODYNAMICS (UDS) USAGE FOR BENIGN PROSTATIC HYPERPLASIA (BPH)
    Thorogood, Samantha L.
    Zhang, Tenny R.
    Sze, Christina
    Strasser, Mary O.
    Demeo, Gina
    Lee, Richard K.
    Chughtai, Bilal
    Te, Alexis
    Hu, Jim C.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E303 - E304
  • [23] Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
    Sciacqua, L. V.
    Vanzulli, A.
    Di Meo, R.
    Pellegrino, G.
    Lavorato, R.
    Vitale, G.
    Carrafiello, G.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [24] PRINCIPLES OF ENDOCRINE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
    ELETREBY, MF
    HABENICHT, UF
    ANTICANCER RESEARCH, 1986, 6 (03) : 391 - 392
  • [25] The role of inflammation in the etiopathogenesis of Benign Prostatic Hyperplasia (BPH)
    Tekin, Ali
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (04): : 15 - 19
  • [26] Herbal medications in the treatment of benign prostatic hyperplasia (BPH)
    Fagelman, E
    Lowe, FC
    UROLOGIC CLINICS OF NORTH AMERICA, 2002, 29 (01) : 23 - +
  • [27] ALPHA-BLOCKADE FOR BENIGN PROSTATIC HYPERPLASIA (BPH)
    LEPOR, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03): : 750 - 753
  • [28] Macrophage infiltration of the stroma in benign prostatic hyperplasia (BPH)
    Gurski, L. A.
    Pascal, L. E.
    Nelson, J. B.
    Pilch, J.
    Wang, Z.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [29] Benign prostatic hyperplasia (BPH). Surgical therapy options
    Reich, O.
    Seitz, M.
    Gratzke, C.
    Schlenker, B.
    Walther, S.
    Stief, C.
    UROLOGE, 2010, 49 (01): : 113 - 124
  • [30] INFLUENCE OF AN AROMATASE INHIBITOR ON BENIGN PROSTATIC HYPERPLASIA (BPH)
    SCHULZE, H
    CLAUS, S
    AKTUELLE UROLOGIE, 1994, 25 (03) : 123 - 132